Last update:

Diseases, Conditions, Syndromes news

Diseases, Conditions, Syndromes

Long COVID patients with abnormal lung CT scans could prove key to preventing pulmonary fibrosis

Long COVID occurs in approximately a third of COVID-19 survivors, with the CDC estimating one in 13 adults in the United States have long COVID symptoms such as brain fog, shortness of breath and chest pain. In a new study ...

Genetics

Scrutinizing cells for clues to a treatment for muscular dystrophy

A research team led by Associate Professor Hidetoshi Sakurai and Researcher Nana Takenaka-Ninagawa recently demonstrated the superior therapeutic potential of iPS cell-derived mesenchymal stromal cells (iMSCs) compared to ...

Diseases, Conditions, Syndromes

U.S. overdose deaths drop 10% in early data

In findings that suggest inroads are being made in the battle against America's opioid epidemic, new government data shows a 10% drop in overdose deaths.

Diseases, Conditions, Syndromes

Scurvy: Not just an 18th-century sailors' disease

Scurvy, or vitamin C deficiency, is not just an 18th-century seafarers' disease, as a case study of a 65-year-old woman with mobility issues and social isolation shows. In an article published in Canadian Medical Association ...

Diseases, Conditions, Syndromes

Mpox epidemic: from first cases to vaccinations

As the Democratic Republic of Congo launches a vaccination campaign amid a flare-up of the sometimes deadly illness mpox, AFP looks at how the virus developed.

Diseases, Conditions, Syndromes

Biomarker can help health care assess severity of COVID-19

Researchers at Karolinska Institutet and the University of Gothenburg have identified a biomarker that could become an important tool for health care in assessing patients with acute COVID-19 infection. The researchers have ...

Diseases, Conditions, Syndromes

WHO approves first mpox diagnostic test

The UN health agency said on Friday that it had approved the use of the first diagnostic test for mpox, a key tool in countries battling outbreaks.

Diseases, Conditions, Syndromes

Modulating type 1 Interferon may expand treatment options for COVID-19

In their continuing work to limit the impact of COVID-19, Emory University researchers have, for the first time in nonhuman primates, studied how modulating the signaling of type 1 Interferon (IFN-I), one of the body's initial ...

Medical research

Researchers find a chink in the armor of tuberculosis pathogen

Mycobacterium tuberculosis (Mtb) is the pathogen that causes tuberculosis (TB), the world's deadliest infectious disease. Mtb is so successful and harmful because it can adapt to different conditions inside our bodies, allowing ...

Diseases, Conditions, Syndromes

Two distinct patient groups ID'd in Meniere disease

For patients with Meniere disease (MD), radiological temporal bone features known to be weakly or inconsistently associated with clinical diagnosis of MD are highly prevalent in one of two MD patient groups, according to ...

Diseases, Conditions, Syndromes

Symptoms of the body and the mind found to be frequent fellow travelers

Chronic pain is often accompanied by depression and anxiety. In an invited commentary published in JAMA Network Open, Kurt Kroenke, M.D., of Regenstrief Institute and Indiana University School of Medicine, discusses the relationship ...

Diseases, Conditions, Syndromes

New tool expands the horizons for neuron sequencing

Ever since 19th-century neuroanatomist Santiago Ramón y Cajal discovered the brain's beautifully complex neurons—what he referred to as "the mysterious butterflies of the soul"—neuroscientists have sought to characterize ...

Diseases, Conditions, Syndromes

Scientists begin to untangle how COVID-19 affects brain cells

Researchers at the Francis Crick Institute have shown in lab-based experiments that variants of SARS-CoV-2, the virus that causes COVID-19, can affect the blood-brain barrier and damage brain cells in different ways. This ...